Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Emicizumab Outcomes in Hemophilia A Using...
Conference

Emicizumab Outcomes in Hemophilia A Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry

Abstract

Abstract Background: The Canadian Hemophilia Bleeding Disorders Registry (CBDR) is a clinical database including data from all Canadian Hemophilia Treatment Centers (HTCs) to assist in the management of hemophilia and other bleeding disorders. The CBDR launched on July 1, 2015 and integrates the data entry platform for patients, myCBDR, allowing direct entry of treatments, bleeding events, and other patient reported outcomes …

Authors

Poon M-C; Lee A; Germini F; Keepanasseril A; Ibrahim Q; Nissen F; Sanabria F; Santos M; Iserman E; Matino D

Volume

138

Publisher

American Society of Hematology

Publication Date

November 5, 2021

DOI

10.1182/blood-2021-147195

Conference proceedings

Blood

Issue

Supplement 1

ISSN

0006-4971